Screener
Allogene Therapeutics ALLO Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Allogene Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
FAQ
- What is Allogene Therapeutics's price / book?
- Allogene Therapeutics (ALLO) reported price / book of 2.1× in Q1 2026.
- How has Allogene Therapeutics's price / book changed year-over-year?
- Allogene Therapeutics's price / book increased by 159.1% year-over-year, from 0.8× to 2.1×.
- What is the long-term trend for Allogene Therapeutics's price / book?
- Over 5 years (2020 to 2025), Allogene Therapeutics's price / book has grown at a -21.6% compound annual growth rate (CAGR), from 3.5× to 1.1×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Allogene Therapeutics's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude